MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$24,684K
Free Cash flow
-$28,975K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sale of common sto...
Operating lease right-of-use ass...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Operating lease liabilities
Accrued expenses and other curre...
Restructuring liability
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
Net loss
-28,919
Stock-based compensation
2,335
Depreciation expense
459
Gain on sale of property and equipment
8
Prepaid expenses and other current assets
-2,069
Operating lease right-of-use assets
-3,132
Accounts payable
-516
Accrued expenses and other current liabilities
-1,811
Restructuring liability
-1,081
Operating lease liabilities
-4,121
Deferred revenue
-398
Net cash used in operating activities
-28,859
Purchases of property and equipment
116
Proceeds from the sale of property and equipment
18
Net cash (used in) provided by investing activities
-98
Proceeds from sale of common stock, warrants and pre-funded warrants
4,999
Payment of deferred offering costs
726
Net cash provided by financing activities
4,273
Net (decrease) increase in cash, cash equivalents and restricted cash
-24,684
Cash, cash equivalents and restricted cash, beginning of period
42,570
Cash, cash equivalents and restricted cash, end of period
17,886
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
common stock, warrants...
$4,999K
Net cash provided by
financing activities
$4,273K
Canceled cashflow
$726K
Net (decrease)
increase in cash, cash...
-$24,684K
Canceled cashflow
$4,273K
Operating lease
right-of-use assets
-$3,132K
Stock-based compensation
$2,335K
Prepaid expenses and
other current assets
-$2,069K
Depreciation expense
$459K
Proceeds from the sale of
property and equipment
$18K
Payment of deferred
offering costs
$726K
Net cash used in
operating activities
-$28,859K
Canceled cashflow
$7,995K
Net cash (used in)
provided by investing...
-$98K
Canceled cashflow
$18K
Net loss
-$28,919K
Operating lease
liabilities
-$4,121K
Accrued expenses and
other current...
-$1,811K
Restructuring liability
-$1,081K
Accounts payable
-$516K
Deferred revenue
-$398K
Gain on sale of
property and equipment
$8K
Purchases of property and
equipment
$116K
Buy us a coffee
Lyra Therapeutics, Inc. (LYRA)
Lyra Therapeutics, Inc. (LYRA)